Yeah look fair play. I suppose I I didn't want to be overly critical of a stock I don't hold. Similarly, I don't believe Nangwarry will make a material difference in share price across the next 3-6 months. I just don't think VEN is getting enough credit for it.
I don't disagree that share price movement has been lacklustre, but as a holder of VEN I don't see there is much they could do differently if they got a do over. I am very open that there is a real chance that we are delayed again, labour is short everywhere. Perhaps in this instance it might be prudent to hedge our bets with another company on retainer? But I don't know how realistic that is.
It's such a cliche on forums like this to hear stories about people trading themselves out of a profit by not sticking to the course, but it is a cliche for a reason. Ever since I stopped making knee jerk reactions to impatience, uncertainty or emotions I started quite profound gains.
- Forums
- ASX - By Stock
- MEL
- Ann: Quarterly Activities and Appendix 5B September 2022
MEL
metgasco ltd
Add to My Watchlist
20.0%
!
0.2¢

Ann: Quarterly Activities and Appendix 5B September 2022, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $3.665M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $360 | 179.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 11172257 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 10182794 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 11172257 | 0.002 |
8 | 35000998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 10182794 | 11 |
0.004 | 10479052 | 6 |
0.006 | 311675 | 1 |
0.022 | 91666 | 1 |
0.028 | 2400 | 1 |
Last trade - 10.09am 25/06/2025 (20 minute delay) ? |
Featured News
MEL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online